Oriental Aromatics Ltd
Oriental Aromatics Q1 FY26 earnings call: Revenue & Margins
Q1 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
The company anticipates steady growth supported by strong customer trust and a diversified portfolio. The company expects incremental sales from recent investments to be about 1.7x over 2 to 3 years.
From Oriental Aromatics Ltd's Q1 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- The company anticipates steady growth supported by strong customer trust and a diversified portfolio.
- Group sales volume grew 4% YoY in Q1 FY26, driven by hydrogenation plant output and initial sales from Mahad facility.
- They expect the Mahad facility ramp-up to continue positively impacting revenue in coming quarters.
- EBITDA margin guidance remains at 8%-10%, with expectations to cross this range over time.
- Incremental sales from recent INR 200+ crore CAPEX are expected to yield 1.7x asset turnover over 2-3 years.
- Broadly, utilization of non-Mahad plants is optimal at 75%-80%, with Mahad plant capacity ramping from 20%-30% towards target.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Oriental Aromatics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company plans to go slow on CAPEX in the current year, opting to pause and evaluate ongoing investments before moving forward.
- There is no firm CAPEX plan currently on the table, but management remains open to opportunities identified by their creative team or through global customer interactions.
- The balance sheet and P&L have leverage, and the company owns land and environmental clearances (EC) to support future investments.
- Past CAPEX includes a brownfield project at Baroda (hydrogenation facility) and a greenfield expansion at Mahad (single product plant Phase 1).
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Oriental Aromatics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The transcript does not explicitly mention the current or expected order book or pending orders for Oriental Aromatics Limited.
- However, the company indicates confidence in its product launches and ongoing engagements, mentioning over 40 products launched in the last 5 years, all globally accepted and running at 70% to 80% plant capacity.
- They highlight challenges in predicting exact timelines due to factors like RFQ (Request for Quotation) windows and customer engagement cycles.
- The management is positive about future opportunities but cautious about exact numbers or timelines for orders.
2 more points management made on order book & pipeline
Oriental Aromatics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹282 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Oriental Aromat.'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Balaji Amines Ltd (Q1 FY26)
Q1FY26 consolidated revenue from operations: ₹367 crore, up 2% quarter-on-quarter from ₹361 crore in Q4FY25, but down 7% year-on-year from ₹393 crore in Q1FY25…
- Linde India Ltd (Q1 FY26)
Net Revenue for FY ended Mar’25 was INR 24,854 million, down 10.2% (–2,833 million) YoY from INR 27,687 million. Key concall takeaways from Linde India Ltd's…
- Vidhi Specialty Food Ingredients Ltd (Q1 FY26)
87.9 Crores . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q1 FY26 earnings call — and how it ranks against sector peers.
- Chemcon Speciality Chemicals Ltd (Q1 FY26)
Q1 FY26 revenue from operations: ₹53.5 Cr, up 18% YoY from ₹45.5 Cr in Q1 FY25 (Page 7 & 6). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q1…
Frequently Asked Questions
What were Oriental Aromatics Ltd Q1 FY26 results?
The company anticipates steady growth supported by strong customer trust and a diversified portfolio. The company expects incremental sales from recent investments to be about 1.7x over 2 to 3 years.
What is Oriental Aromatics Ltd share price analysis?
Oriental Aromatics Ltd currently shows a neutral. The stock trades at a P/E of 220.2 with a market cap of ₹1,171 Cr. Investors should review the full earnings analysis for detailed insights.
Is Oriental Aromatics Ltd planning capital expenditure?
The company plans to go slow on CAPEX in the current year, opting to pause and evaluate ongoing investments before moving forward.
Keep Oriental Aromatics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.